Q3 2024 Plus Therapeutics Inc Earnings Call Transcript

Author's Avatar
Nov 15, 2024

Nov 14, 2024 / 10:00PM GMT
Operator

Good afternoon. Ladies and gentlemen, welcome to the Plus Therapeutics third quarter, 2024 results conference call. Before we begin, we want to advise you that over the course of the call, including any question and answer session. Forward-looking statements will be made regarding events, trends, business prospects and financial performance which may affect plus therapeutics', future operating results and financial position. All such statements are subject to risks and uncertainties including the risks and uncertainties described under the risk factors section included in Plus therapeutics', annual report on form 10-K and quarterly reports on form 10-Q filed with the Securities and Exchange Commission from time to time. Plus therapeutics advises you to review these risk factors in considering such statements. Plus therapeutics assumes no responsibility to update or revise any forward-looking statements to reflect events, trends or circumstances after the date they are made.

It is now my pleasure to turn the floor over to Dr Mark Hedrick Plus Therapeutics, President and Chief Executive Officer, sir

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot